The American Hospital Association expresses concern about Eli Lilly’s January 2026 claims-data policy and invites Lilly to work in good faith with the AHA and our 340B hospital members to find a better path forward than the cycle of escalation that has beset the 340B program in recent years.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
The American Hospital Association expresses support for the Medicare Advantage Improvement Act (S. 4384).
The American Hospital Association expresses support for the Medicare Advantage Improvement Act (H.R. 8375).
AHA comments on the Centers for Medicare & Medicaid Services’ revised Medicare Part C and D Reporting requirements.
The AHA asks that as the Senate begins drafting the FY 2027 appropriations bill, it funds health care programs that have proven successful in improving access to quality health care for patients and communities across America.
The AHA asks that as the House begins drafting the FY 2027 appropriations bill, it funds health care programs that have proven successful in improving access to quality health care for patients and communities across America.
The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number of drug company policies requiring covered entities to submit onerous amounts of claims data in exchange for their statutorily owed 340B discounts.
AHA comments on the Trusted Exchange Framework and Common Agreement (TEFCA) Individual Access Services (IAS) Exchange Purpose (XP) Standard Operating Procedures (SOP) version 3.0.
The AHA responds to the Health Resources and Services Administration’s (HRSA) Request for Information regarding a potential 340B Rebate Model Pilot Program.
We, the undersigned organizations, strongly endorse the Chronic Care Management Improvement Act of 2026 to ensure that more chronically ill Medicare patients receive access to high-quality care.